Search research articles
Contact Us
Filters
Showing results (51-60 of 81) with videos related to
Page
of 9
Sort By:
Neurobiology of Disease
|
February 15, 2003
Huntington's disease of the endocrine pancreas: insulin deficiency and diabetes mellitus due to impaired insulin gene expression
Ole A Andreassen, Alpaslan Dedeoglu, Violeta Stanojevic, et al.
The Journal of Biological Chemistry
|
October 21, 2004
Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease
Gabriella Gardian, Susan E Browne, Dong-Kug Choi, et al.
Journal of Neurochemistry
|
June 7, 2005
Sodium phenylbutyrate prolongs survival and regulates expression of anti-apoptotic genes in transgenic amyotrophic lateral sclerosis mice
Hoon Ryu, Karen Smith, Sandra I Camelo, et al.
Biochimica Et Biophysica Acta
|
December 21, 2005
Combination therapy using minocycline and coenzyme Q10 in R6/2 transgenic Huntington's disease mice
Edward C Stack, Karen M Smith, Hoon Ryu, et al.
Journal of Neurochemistry
|
September 13, 2003
Depletion of wild-type huntingtin in mouse models of neurologic diseases
Yu Zhang, Mingwei Li, Martin Drozda, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
October 17, 2003
Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice
Robert J Ferrante, James K Kubilus, Junghee Lee, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
July 2, 2004
Prophylactic creatine administration mediates neuroprotection in cerebral ischemia in mice
Shan Zhu, Mingwei Li, Bryan E Figueroa, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 5, 2011
Transcriptional modulator H2A histone family, member Y (H2AFY) marks Huntington disease activity in man and mouse
Yi Hu, Vanita Chopra, Raman Chopra, et al.
Frontiers in Bioscience (Elite Edition)
|
June 2, 2012
A high-throughput screen to identify inhibitors of SOD1 transcription
Paul D Wright, Nicholas Wightman, Mickey Huang, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
September 19, 2008
Inhibitors of cytochrome c release with therapeutic potential for Huntington's disease
Xin Wang, Shan Zhu, Zhijuan Pei, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 81) with videos related to
Sort By:
Page
of 9
Neurobiology of Disease
|
February 15, 2003
Huntington's disease of the endocrine pancreas: insulin deficiency and diabetes mellitus due to impaired insulin gene expression
Ole A Andreassen, Alpaslan Dedeoglu, Violeta Stanojevic, et al.
The Journal of Biological Chemistry
|
October 21, 2004
Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease
Gabriella Gardian, Susan E Browne, Dong-Kug Choi, et al.
Journal of Neurochemistry
|
June 7, 2005
Sodium phenylbutyrate prolongs survival and regulates expression of anti-apoptotic genes in transgenic amyotrophic lateral sclerosis mice
Hoon Ryu, Karen Smith, Sandra I Camelo, et al.
Biochimica Et Biophysica Acta
|
December 21, 2005
Combination therapy using minocycline and coenzyme Q10 in R6/2 transgenic Huntington's disease mice
Edward C Stack, Karen M Smith, Hoon Ryu, et al.
Journal of Neurochemistry
|
September 13, 2003
Depletion of wild-type huntingtin in mouse models of neurologic diseases
Yu Zhang, Mingwei Li, Martin Drozda, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
October 17, 2003
Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice
Robert J Ferrante, James K Kubilus, Junghee Lee, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
July 2, 2004
Prophylactic creatine administration mediates neuroprotection in cerebral ischemia in mice
Shan Zhu, Mingwei Li, Bryan E Figueroa, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 5, 2011
Transcriptional modulator H2A histone family, member Y (H2AFY) marks Huntington disease activity in man and mouse
Yi Hu, Vanita Chopra, Raman Chopra, et al.
Frontiers in Bioscience (Elite Edition)
|
June 2, 2012
A high-throughput screen to identify inhibitors of SOD1 transcription
Paul D Wright, Nicholas Wightman, Mickey Huang, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
September 19, 2008
Inhibitors of cytochrome c release with therapeutic potential for Huntington's disease
Xin Wang, Shan Zhu, Zhijuan Pei, et al.
Page
of 9